CN102266528B - Medicament for treating hypertension - Google Patents
Medicament for treating hypertension Download PDFInfo
- Publication number
- CN102266528B CN102266528B CN2011101870677A CN201110187067A CN102266528B CN 102266528 B CN102266528 B CN 102266528B CN 2011101870677 A CN2011101870677 A CN 2011101870677A CN 201110187067 A CN201110187067 A CN 201110187067A CN 102266528 B CN102266528 B CN 102266528B
- Authority
- CN
- China
- Prior art keywords
- parts
- weight portions
- blood pressure
- hypertension
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for treating hypertension, prepared from the following medicines in parts by weight: 20 parts of dendrobe, 20 parts of wild chrysanthemum flower, 20 parts of radix scrophulariae, 20 parts of tuckahoe, 20 parts of oriental waterplantain rhizome, 15 parts of rehmannia root, 15 parts of baikal skullcap root, 20 parts of curcuma, 20 parts of eucommia, 30 parts of achyranthes root, 30 parts of mother-of-pearl, 15 parts of lotus nut, 30 parts of portulaca oleracea, 30 parts of kendir, 20 parts of sophora flower-bud and 20 parts of gastrodia tuber. The prescription composition integrates a classical prescription, modern medicine research and an empirical prescription, has better therapeutic effect on hypertension, and has reasonable combination, no contraindication and no toxic side effect, thus can be taken often, and clinical data shows that the cure rate is as high as 99.9%.
Description
Technical field
The present invention relates to the hypertensive medicine of a kind of treatment.
Background technology
Blood pressure comprises heart contraction, with maximal blood pressure (systolic blood pressure) and the diastole of blood when tremulous pulse is seen off, the minimal blood pressure (diastolic blood pressure) when blood is full of heart, so-called hypertension is meant any rising in the two.According to the standard of The World Health Organization (WHO), maximal blood pressure is defined as vascular hypertension above any one situation that 140mmHg, minimal blood pressure surpass 90mmHg.Vascular hypertension comprises unascertainable essential hypertension disease of its reason and the clear and definite secondary hypertension disease of reason, in vascular hypertension, is essential hypertension disease more than 90%.This case many middle age with sequela, the chronic course of disease, but attack rate is high, causes the damage of main organs such as brain, the heart, kidney, influences the course of disease of arteriosclerotic disease in addition closely, therefore, occupies the anteposition of the cause of death in the world.
Summary of the invention
Technical problem to be solved by this invention provides the hypertensive medicine of a kind of treatment.
The hypertensive medicine of a kind of treatment is according to following weight portion compounding pharmaceutical: Herba Dendrobii 20 weight portions, Flos Chrysanthemi Indici 20 weight portions, Radix Scrophulariae 20 weight portions, Poria 20 weight portions; Rhizoma Alismatis 20 weight portions, the Radix Rehmanniae 15 weight portions, Radix Scutellariae 15 weight portions, Rhizoma Curcumae Longae 20 weight portions; The Cortex Eucommiae 20 weight portions, Radix Achyranthis Bidentatae 30 weight portions, Concha Margaritifera 30 weight portions, Plumula Nelumbinis 15 weight portions; Herba Portulacae 30 weight portions, Herba Apocyni veneti 30 weight portions, the Flos Sophorae Immaturus 20 weight portions, Rhizoma Gastrodiae 20 weight portions.
The hypertensive medicine of described treatment, it is powder that said medicine is pulverized, with No. 0 capsule powder charge end, every capsules powder charge end 0.45g.
Side's medicine is formed and is integrated classical prescription, modern medicine study, proved recipe, and hypertension is had better therapeutic effect.Compatibility is proper, nothing is avoided, had no side effect, so but informal dress, clinical data shows that healing reaches 99.9%.
The specific embodiment
Below in conjunction with specific embodiment, the present invention is elaborated.
Embodiment 1 side's medicine is formed
According to following weight portion compounding pharmaceutical: Herba Dendrobii 20 weight portions, Flos Chrysanthemi Indici 20 weight portions, Radix Scrophulariae 20 weight portions, Poria 20 weight portions; Rhizoma Alismatis 20 weight portions, the Radix Rehmanniae 15 weight portions, Radix Scutellariae 15 weight portions, Rhizoma Curcumae Longae 20 weight portions; The Cortex Eucommiae 20 weight portions, Radix Achyranthis Bidentatae 30 weight portions, Concha Margaritifera 30 weight portions, Plumula Nelumbinis 15 weight portions; Herba Portulacae 30 weight portions, Herba Apocyni veneti 30 weight portions, the Flos Sophorae Immaturus 20 weight portions, Rhizoma Gastrodiae 20 weight portions.
It is powder that said medicine is pulverized, with No. 0 capsule powder charge end, and every capsules powder charge end 0.45g, 60 every bottle.
The function of medicine: nourishing YIN to lower pathogenic fire improving blood circulation and reducing fat disperse blood stasis and dredge collateral YIN and YANG balance regulating.Cure mainly: but dizziness headache that blood pressure diseases and hypertension causes, uncomfortable in chest, arteriosclerosis, hyperviscous hyperlipemia, while prevention of cerebral hemorrhage, cerebral infarction specially controlled.
Embodiment 2 clinical experiment data
The blood pressure decreasing capsule that usage and dosage: embodiment 1 provides, each 4, every day 3 times, serve on 10 days after, treat blood pressure reduce to normal after, reduce consumption to maintenance dose 1 each 2-3 grain every day gradually.
Ordinary circumstance, male's 380 examples, women's 315 examples, minimum 28 years old of age, the oldest 72 years old, 150 examples below 40 years old, 545 examples more than 50 years old.
The course of disease: the shortest 10 days, the longest 15 years, wherein account for more than 15%, one year the person half a year and account for that the person accounts for 42% more than 33%, five year.
The cause of disease: concurrent diabetes 35 people of arteriosclerosis 350 people's hyperlipemias 330 people
Clinical manifestation: one-level hypertension 250 people
Secondary hypertension 280 people
Three grades of hypertension 165 people
Chemical examination detects: high person 330 people 44.7% of cholesterol
High person 350 people 50.3% of triglyceride
High person 35 people 8.8% of blood glucose
1) curative effect judging standard:
A: invalid: blood pressure no change after the week of taking medicine;
B: effectively: the bleeding from anus of taking medicine be pressed with descend, but blood pressure lowering is abnormal;
C: produce effects: the back blood pressure drops of taking medicine but has fluctuation to standard;
D: the basic healing: the back blood pressure of taking medicine is up to standard, takes maintenance dose every day;
2) therapeutic outcome:
Treat 695 people, effective 83 people, produce effects 150 people cure 455 people basically, invalid 7 people, effective percentage accounts for 99%.
Model case 1:
Korea Spro * * man, 54 years old, Shijiazhuang, Hebei cadre, hypertension history 15 years has the tobacco and wine history usually, and symptoms such as uncomfortable in chest, dizziness are often arranged, and blood pressure 170/110mmng takes nifedipine, captopril.Blood pressure can be controlled, but fluctuation is bigger after meeting tired back and emotion changes by chance.Symptoms such as normal companion is uncomfortable in chest, breathe hard, dizziness are through taking blood pressure decreasing capsule (each 4, every day 3 times) about 10 days; Controlling of blood pressure is at 130/85mmng, and dizzy, the uncomfortable in chest and transference cure of breathing hard is taken (1 time 3 of maintenance doses every day; Every day 1 time) blood pressure is up to standard always, from May, 2009 so far.
Model case 2:
Yan so-and-so: woman, 65 years old, Xianyang hospital personnel, hypertension history 15 years, diabetic history 3 years.Its symptom is often felt headache and dizzy and is met the above sx in tired back; Have a blood test fat, triglyceride 3.7mmol/L fasting glucose 7.6mmol glycolated hemoglobin 7.5mmol/L of blood pressure 160/110mmng is taken blood pressure decreasing capsule blood pressure 120/80mmng transference cure from May, 2007; After blood glucose also had clear improvement, it was so far up to standard to use the maintenance dose blood pressure instead.
The pharmacological action basis:
Herba Dendrobii, the Radix Rehmanniae, Radix Scrophulariae YIN nourishing press down yang hyperactivity in the side, Cortex Eucommiae regulating QI Yin bivacuity Poria Rhizoma Alismatis, the logical merit just, the little sour promote blood circulation to disperse blood clot of Radix Achyranthis Bidentatae bitter in the mouth turned down of dampness removing; Shape under the dredge the meridian passage priming; Its property keeps dropping, and has bringing high blood pressure down, promotes lipid metabolism, the cholesterol reducing effect.Radix Scutellariae, Spica Prunellae, bring high blood pressure down in the hope of relief of symptoms to strengthen the merit of purging liver-fire.The modern medicine study flavonoid is the most important material that human body keeps blood circulation, cholesterol reducing, balancing blood pressure, as long as keep in the body flavones content can keep blood fat, blood pressure steady.Semen Cassiae, the Flos Sophorae Immaturus, Radix Polygoni Multiflori Preparata, Spica Prunellae, Flos Chrysanthemi are the natural materials of high flavones content, and Plumula Nelumbinis has stronger hypotensive effect.Multiple anti-experimental character arrhythmia, expansion of cerebral vascular reverse, resisting vascular smooth muscle cell proliferation effect are arranged.
Flos Chrysanthemi, Concha Margaritifera, Rhizoma Gastrodiae, Semen Cassiae, Radix Puerariae etc. have effects such as heat-clearing and toxic substances removing, liver heat removing and eyesight improving, calmness and dizziness relieving, tonneau urine.
Claims (2)
1. the hypertensive medicine of treatment is characterized in that, according to following weight portion compounding pharmaceutical: Herba Dendrobii 20 weight portions, Flos Chrysanthemi Indici 20 weight portions, Radix Scrophulariae 20 weight portions; Poria 20 weight portions, Rhizoma Alismatis 20 weight portions, the Radix Rehmanniae 15 weight portions, Radix Scutellariae 15 weight portions, Rhizoma Curcumae Longae 20 weight portions; The Cortex Eucommiae 20 weight portions, Radix Achyranthis Bidentatae 30 weight portions, Concha Margaritifera 30 weight portions, Plumula Nelumbinis 15 weight portions; Herba Portulacae 30 weight portions, Herba Apocyni veneti 30 weight portions, the Flos Sophorae Immaturus 20 weight portions, Rhizoma Gastrodiae 20 weight portions.
2. the hypertensive medicine of treatment according to claim 1 is characterized in that, said medicine pulverized be powder, and with No. 0 capsule powder charge end, every capsules powder charge end 0.45g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101870677A CN102266528B (en) | 2011-07-06 | 2011-07-06 | Medicament for treating hypertension |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101870677A CN102266528B (en) | 2011-07-06 | 2011-07-06 | Medicament for treating hypertension |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102266528A CN102266528A (en) | 2011-12-07 |
| CN102266528B true CN102266528B (en) | 2012-08-15 |
Family
ID=45049108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011101870677A Expired - Fee Related CN102266528B (en) | 2011-07-06 | 2011-07-06 | Medicament for treating hypertension |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102266528B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106110294A (en) * | 2016-06-29 | 2016-11-16 | 中科和素（天津）医药科技有限公司 | A kind of nutritional preparation repairing damaged islet cells and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810801A (en) * | 2010-05-30 | 2010-08-25 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating hypertension and preparation method thereof |
-
2011
- 2011-07-06 CN CN2011101870677A patent/CN102266528B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810801A (en) * | 2010-05-30 | 2010-08-25 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating hypertension and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 屠庆祝等.中药治疗高血压的用药规律探要.《实用中医内科杂志》.2005,第19卷(第01期),84-85. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102266528A (en) | 2011-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102228525B (en) | Traditional Chinese medicine for treating cardio-cerebral vascular stagnation | |
| CN100382839C (en) | Chinese-medicinal composition for treating coronary heart disease | |
| CN102406911B (en) | Chinese medicine preparation for treating coronary heart disease | |
| CN101843661B (en) | Chinese medicament for treating angina | |
| CN101979020A (en) | Chinese medicinal preparation for treating high blood pressure | |
| CN103417718A (en) | Pressure-reduction and fat-eliminating tea | |
| CN102266528B (en) | Medicament for treating hypertension | |
| CN100455313C (en) | Chinese medicine for treating cardiovascular and cerebrovascular disease | |
| CN105596735A (en) | Medicine composition for treating diabetes mellitus | |
| CN104940516B (en) | A kind of Chinese medicine composition for treating chronic aplastic anemia and preparation method and application | |
| CN103479895A (en) | Heart comforting and brain clearing traditional Chinese medicine composition | |
| CN102302550A (en) | Medicament for treating coronary heart disease | |
| CN101843712B (en) | Chinese medicament for treating angina | |
| CN101181327B (en) | Chinese medicine compound preparations for preventing and curing cataptosis and chest bi-syndrome as well as preparation method thereof | |
| CN101716271B (en) | Chinese traditional medicine effective fraction composite used for curing coronary heart disease and preparation method thereof | |
| CN101797330B (en) | Lipid regulating and meridians activating capsule | |
| CN101843717B (en) | Chinese medicament for treating coronary disease | |
| CN101843758B (en) | Chinese medicament for treating coronary disease | |
| CN110215505A (en) | A kind of qi-deficiency type constitution supplementing qi and invigorating vasculum, the Chinese medicine composition throbbed with fear surely of calming the nerves | |
| CN101843672B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101849985B (en) | Chinese medicament for treating tachycardia | |
| CN101172126B (en) | Traditional Chinese medicine composition for health care beauty treatment | |
| CN101843647B (en) | Chinese medicament for treating angina | |
| CN101843673B (en) | Chinese medicament for treating arteriosclerosis | |
| CN103751512A (en) | Traditional Chinese medicament for treating diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120815 Termination date: 20140706 |
|
| EXPY | Termination of patent right or utility model |